Introduction to Biological and Small Molecule Drug Research and Development Theory and Case Studies

Name: Introduction to Biological and Small Molecule Drug Research and Development Theory and Case Studies
Price: 87.54 USD
Availability: InStock
ISBN: 9780123971760

ISBN-10: 0123971764

ISBN-13: 9780123971760

Edition: 2013

Authors: Robin Ganellin, Roy Jefferies, Stanley M. Roberts

List price: $65.99

30 day, 100% satisfaction guarantee!

Marketplace

1 new & used from $87.54

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

The fundamental concept of the book is to provide, for the first time, an introduction to understand the science behind successful pharmaceutical research and development programs. As well as explaining the basic principles, the book compares and contrasts approaches to both biopharmaceuticals (proteins) and small molecule drugs and presents an overview of the business and management issues for these approaches. The second part of the book provides 9 carefully selected real life case studies to illustrate how the theory presented in the first part of the book is actually being put into practice. Introduction to Biological and Small Molecule Drug Research and Development is intended for…

Book details

List price: $65.99
Copyright year: 2013
Publisher: Elsevier
Publication date: 5/29/2013
Binding: Hardcover
Pages: 472
Size: 7.80" wide x 9.50" long x 1.00" tall
Weight: 2.442
Language: English

Michael J Palmer is a Senior Principal Scientist at Pfizer. He has worldwide medicinal chemistry and drug discovery based experience across many different therapeutic areas. He is a member of the drug discovery teams responsible for carduraTM, additional cardiovascular agents that progressed to man, and cardiovascular and antiviral agents in Phase I and II stages of development.Timothy NC Wells is Chief Scientific Officer at Medicines for Malaria Venture, Geneva, Switzerland.